Ocular Therapeutix Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,438	2,203	1,297	445	202	470
Market Cap Growth	17.17%	69.86%	191.61%	119.64%	-56.87%	-63.15%
Enterprise Value	877	1,975	957	420	145	364
Last Close Price	6.11	10.31	7.97	4.17	2.57	5.80
PS Ratio	32.49	49.79	21.07	8.41	4.20	12.27
PB Ratio	2.58	3.95	4.26	5.39	6.12	6.07
P/TBV Ratio	2.58	3.95	4.26	5.39	6.12	6.07
EV/Sales Ratio	19.89	44.63	15.54	7.94	3.01	9.50
Debt / Equity Ratio	0.12	0.12	0.24	0.92	1.82	0.67
Net Debt / Equity Ratio	-1.01	-1.01	-1.00	-1.23	-1.07	-1.19
Net Debt / EBITDA Ratio	2.48	2.48	2.01	1.42	0.50	1.39
Net Debt / FCF Ratio	3.04	3.04	2.33	1.47	0.60	1.58
Asset Turnover	0.08	0.08	0.18	0.29	0.29	0.19
Inventory Turnover	61.68	61.68	49.86	31.01	35.98	44.46
Quick Ratio	15.11	15.11	10.27	6.36	3.94	7.04
Current Ratio	15.39	15.39	10.66	6.66	4.13	7.26
Return on Equity (ROE)	-54.85%	-54.85%	-95.21%	-127.64%	-115.16%	-7.99%
Return on Assets (ROA)	-26.66%	-26.66%	-28.32%	-25.66%	-27.76%	-20.90%
Return on Capital Employed (ROCE)	-35.70%	-35.70%	-38.60%	-37.90%	-66.70%	-43.70%
Earnings Yield	-15.76%	-10.28%	-14.41%	-16.42%	-32.83%	-1.23%
FCF Yield	-12.85%	-8.39%	-10.13%	-15.53%	-29.26%	-12.50%
Buyback Yield / Dilution	-18.31%	-18.31%	-84.90%	-3.57%	-0.59%	-35.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.